1
|
Bayrak O, Aksay E, Oray NC, Bayram B, Sakar S. Does salbutamol associated with increase in lactate levels in emergency department patients? J Crit Care 2020; 61:29-33. [PMID: 33070026 DOI: 10.1016/j.jcrc.2020.09.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 09/10/2020] [Accepted: 09/17/2020] [Indexed: 10/23/2022]
Affiliation(s)
- Ozlem Bayrak
- Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Turkey
| | - Ersin Aksay
- Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Turkey.
| | | | - Basak Bayram
- Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Turkey
| | - Sebnem Sakar
- Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Turkey
| |
Collapse
|
2
|
Liedtke AG, Lava SAG, Milani GP, Agostoni C, Gilardi V, Bianchetti MG, Treglia G, Faré PB. Selective ß2-Adrenoceptor Agonists and Relevant Hyperlactatemia: Systematic Review and Meta-Analysis. J Clin Med 2019; 9:jcm9010071. [PMID: 31892109 PMCID: PMC7019948 DOI: 10.3390/jcm9010071] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 12/20/2019] [Accepted: 12/22/2019] [Indexed: 12/28/2022] Open
Abstract
Selective ß2-agonists have been imputed as potential cause of l-hyperlactatemia since the 1970s. To document the prevalence of hyperlactatemia associated with selective ß2-agonists and to investigate the predisposing factors, we searched for published articles until April 2019 pertaining to the interplay of administration of selective ß2-agonists and circulating l-lactic acid in the Excerpta Medica, Web of Science, and the U.S. National Library of Medicine databases. Out of the 1834 initially retrieved records, 56 articles were included: 42 papers reporting individual cases, 2 observational studies, and 12 clinical trials. Forty-seven individual patients receiving a selective ß2-agonist were found to have l-lactatemia ≥5.0 mmol/L, which decreased by ≥3.0 mmol/L or to ≤2.5 mmol/L after discontinuing (N = 24), reducing (N = 17) or without modifying the dosage of the selective ß2-agonist (N = 6). Clinical trials found that l-lactic acid significantly increased in healthy volunteers administered a ß2-agonist. l-lactatemia ≥5.0 mmol/L was observed in 103 (24%) out of 426 patients with asthma or preterm labor managed with a selective ß2-agonist and was more common in patients with asthma (30%) than in premature labor (5.9%). A significant relationship was also noted between l-lactate level and intravenous albuterol dose or its circulating level. In conclusion, relevant l-hyperlactatemia is common on high dose treatment with a selective ß2-agonist.
Collapse
Affiliation(s)
- Alina G. Liedtke
- Department of Internal Medicine, Ente Ospedaliero Cantonale, 6600 Locarno, Switzerland; (A.G.L.); (P.B.F.)
| | - Sebastiano A. G. Lava
- Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, 1010 Lausanne, Switzerland;
| | - Gregorio P. Milani
- Pediatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy;
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy
- Correspondence:
| | - Carlo Agostoni
- Pediatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy;
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy
| | - Viola Gilardi
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland; (V.G.); (M.G.B.)
| | - Mario G. Bianchetti
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland; (V.G.); (M.G.B.)
- Pediatric Institute of Southern Switzerland, Ospedale San Giovanni, 6500 Bellinzona, Switzerland
| | - Giorgio Treglia
- Academic Education, Research and Innovation Area, General Directorate, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland;
- Faculty of Biology and Medicine, University of Lausanne, 1000 Lausanne, Switzerland
| | - Pietro B. Faré
- Department of Internal Medicine, Ente Ospedaliero Cantonale, 6600 Locarno, Switzerland; (A.G.L.); (P.B.F.)
| |
Collapse
|
3
|
Fritsch N, Gentile A, Kearns K, Benois A, Fontaine B. [Investigation about a lactic acidosis]. Ann Fr Anesth Reanim 2010; 29:925-926. [PMID: 21109388 DOI: 10.1016/j.annfar.2010.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2010] [Accepted: 10/13/2010] [Indexed: 05/30/2023]
|
4
|
Gómez Bustos M, García Ron A, Ibarra de la Rosa I, Pérez Navero J. Acidosis láctica secundaria a inhalación de dosis elevadas de salbutamol. An Pediatr (Barc) 2008; 69:586-7. [DOI: 10.1016/s1695-4033(08)75251-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
5
|
Bordes J, Meaudre E, Asencio Y, Montcriol A, Kaiser E. [Lactic acidosis associated with propofol during general anaesthesia for neurosurgery]. ACTA ACUST UNITED AC 2008; 27:261-4. [PMID: 18313882 DOI: 10.1016/j.annfar.2008.01.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2007] [Accepted: 01/17/2008] [Indexed: 11/23/2022]
Abstract
Propofol infusion syndrome (PRIS) is a new clinical entity reported in critically ill patients. Lactic acidosis, cardiac failure and rhabdomyolysis are the features. Lactic acidosis related to short-term propofol administration has been described during general anaesthesia. Lactic acidosis could be an early marker of PRIS. We report here a case of very early lactic acidosis in a 66-year-old-man receiving propofol during a neurosurgery. The outcome was good after discontinuation of propofol.
Collapse
|